Entrada Therapeutics, Inc. (TRDA)

NASDAQ: TRDA · Real-Time Price · USD

7.74

+0.59 (8.25%)

At close: Jun 26, 2026, 4:00 PM EDT

7.60

-0.14 (-1.81%)

After-hours: Jun 26, 2026, 7:33 PM EDT

Entrada Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	76.44	90.39	101.21	67.6	45.16	291.06
Short-Term Investments	178.42	205.3	318.79	284.37	143.56	-
Cash & Short-Term Investments	254.86	295.7	420	351.97	188.71	291.06
Cash Growth	-33.37%	-29.59%	19.33%	86.51%	-35.16%	645.46%
Accounts Receivable	0.79	1.18	3.68	5.88	-	-
Other Current Assets	11.23	9.38	16.36	11.92	21.16	7.64
Total Current Assets	266.87	306.25	440.04	369.77	209.88	298.7
Net Property, Plant & Equipment	65.26	67.76	82.05	92.68	33.02	6.26
Other Long-Term Assets	3.38	3.36	4.23	6.74	9.16	0.87
Total Assets	335.52	377.38	526.32	469.19	252.06	305.83
Accounts Payable	2.93	2.29	4.26	3.28	5.99	0.71
Accrued Expenses	11.73	17.68	13.34	11.33	7.58	6.01
Current Portion of Leases	4.28	4.14	7.56	7.91	8.41	-
Unearned Revenue	0.25	0.34	13.65	132.26	-	-
Other Current Liabilities	-	-	0.67	4.02	-	-
Total Current Liabilities	19.2	24.45	39.48	158.8	21.97	6.72
Long-Term Leases	45.47	46.79	51.65	60.32	17.53	-
Other Long-Term Liabilities	-	-	6.51	7.72	-	0.4
Total Long-Term Liabilities	45.47	46.79	58.16	68.04	17.53	0.4
Total Liabilities	64.66	71.25	97.64	226.83	39.5	7.12
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	583.42	578.57	558.06	437.13	402.89	392.38
Accumulated Other Comprehensive Income	0.25	0.65	-0.04	0.2	-2.06	-
Retained Earnings	-312.81	-273.09	-129.34	-194.97	-188.29	-93.67
Total Common Shareholders' Equity	270.85	306.13	428.68	242.36	212.55	298.72
Shareholders' Equity	270.85	306.13	428.68	242.36	212.55	298.72
Total Liabilities & Equity	335.52	377.38	526.32	469.19	252.06	305.83
Total Debt	49.75	50.93	59.21	68.23	25.94	0
Net Cash (Debt)	205.11	244.77	360.79	283.74	162.78	291.06
Net Cash Growth	-16.20%	-32.16%	27.16%	74.31%	-44.08%	645.46%
Net Cash Per Share	4.93	5.92	9.25	8.59	5.20	46.44
Book Value	270.85	306.13	428.68	242.36	212.55	298.72
Book Value Per Share	6.52	7.40	10.99	7.33	6.79	47.66
Tangible Book Value	270.85	306.13	428.68	242.36	212.55	298.72
Tangible Book Value Per Share	6.52	7.40	10.99	7.33	6.79	47.66

SEC Filings: 10-K · 10-Q